Analyst Ratings for OncoMed Pharmaceuticals (OMED)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 1.3 / 10
Percentile Rank: 17%
Rating Score: 1.3 / 10
Percentile Rank: 17%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/6/2018 | Jefferies | Maury Raycroft | Downgrade | Hold (Buy) |
1.50 (5.50) |
1.11 (0.89) |
-19.82% | Details |
| 12/6/2018 | Wells Fargo | Jim Birchenough | Downgrade | Equal Weight (Overweight) |
1.50 (8.00) |
1.11 (0.89) |
-19.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
